Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study.

Adjusted proportions remaining on drug and with low pain were numerically higher for patients treated with a JAKi compared with patients treated with a TNFi or an IL‐6i, although the differences did not reach statistical significance (Figure 2 ).

also in 111,027 other papers